{"organizations": [], "uuid": "3e5d8425a38681f1e7574ec99f9acbf5990b80c1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-baker-bros-advisors-lp-reports-89/brief-baker-bros-advisors-lp-reports-8-9-pct-passive-stake-in-tonix-pharmaceuticals-holding-as-of-dec-31-2017-sec-filing-idUSFWN1Q31H6", "country": "US", "domain_rank": 408, "title": "Baker Bros Advisors LP Reports 8.9 Pct Passive Stake In Tonix Pharmaceuticals Holding As Of Dec 31, 2017 - SEC Filing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T05:49:00.000+02:00", "replies_count": 0, "uuid": "3e5d8425a38681f1e7574ec99f9acbf5990b80c1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-baker-bros-advisors-lp-reports-89/brief-baker-bros-advisors-lp-reports-8-9-pct-passive-stake-in-tonix-pharmaceuticals-holding-as-of-dec-31-2017-sec-filing-idUSFWN1Q31H6", "ord_in_thread": 0, "title": "Baker Bros Advisors LP Reports 8.9 Pct Passive Stake In Tonix Pharmaceuticals Holding As Of Dec 31, 2017 - SEC Filing", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "baker bros advisors lp", "sentiment": "negative"}, {"name": "tonix pharmaceuticals", "sentiment": "negative"}, {"name": "reuters) - tonix pharmaceuticals holding corp", "sentiment": "neutral"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Tonix Pharmaceuticals Holding Corp :\n* BAKER BROS ADVISORS LP REPORTS 8.9 PERCENT PASSIVE STAKE IN TONIX PHARMACEUTICALS HOLDING AS OF DEC 31, 2017 - SEC FILING Source text: ( bit.ly/2HcDj6B ) Further company coverage:\n ", "external_links": ["http://bit.ly/2HcDj6B", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T05:49:00.000+02:00", "crawled": "2018-02-14T12:52:08.033+02:00", "highlightTitle": ""}